VBLT logo

Vascular Biogenics (VBLT) Cash From Financing

Annual CFF

$22.00 K
-$49.09 M-99.96%

December 31, 2022

Summary

Performance

1-Year Change

-99.96%

3-Year Change

+106.13%

5-Year Change

-99.89%

15-Year Change

-99.89%

VBLT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$49.11 M
VBLT annual cash flow from financing activities is currently -99.96% below its historical high of $49.11 million

3-Year Low

$22.00 K
VBLT annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
VBLT previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
VBLT next annual earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

Annual CFI

$27.30 M
VBLT annual cash flow from investing activities is $27.30 million

Annual CFO

-$31.59 M
VBLT annual cash flow from operations is -$31.59 million

Annual FCF

-$32.41 M
VBLT annual free cash flow is -$32.41 million

Annual CAPEX

$812.00 K
VBLT annual capital expenditures is $812.00 thousand

Quarterly CFF

$1000.00
NaN%

June 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

+100%

3-Year Change

-99.99%

5-Year Change

-99.99%

VBLT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$34.88 M
VBLT quarterly cash flow from financing activities is currently -100.00% below its historical high of $34.88 million

3-Year Low

$0.00
VBLT quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
VBLT previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
VBLT next earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

Quarterly CFI

$186.00 K
VBLT quarterly cash flow from investing activities is $186.00 thousand

Quarterly CFO

-$2.36 M
VBLT quarterly cash flow from operations is -$2.36 million

Quarterly FCF

-$2.36 M
VBLT quarterly free cash flow is -$2.36 million

Quarterly CAPEX

-
VBLT quarterly capital expenditures value is unknown

TTM CFF

$23.00 K
NaN%

June 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-99.79%

3-Year Change

-99.86%

5-Year Change

+106.41%

VBLT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$49.11 M
VBLT TTM cash flow from financing activities is currently -99.95% below its historical high of $49.11 million

3-Year Low

$22.00 K
VBLT TTM cash flow from financing activities is currently +4.55% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
VBLT previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
VBLT next earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

TTM CFI

$26.32 M
VBLT TTM cash flow from investing activities is $26.32 million

TTM CFO

-$17.59 M
VBLT TTM cash flow from operations is -$17.59 million

TTM FCF

-$17.56 M
VBLT TTM free cash flow is -$17.56 million

TTM CAPEX

-
VBLT TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VBLT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%+100.0%-99.8%
3 y3 years+106.1%-100.0%-99.9%
5 y5 years-99.9%-100.0%+106.4%

VBLT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%-100.0%-100.0%-4.3%
5 y5-year-100.0%-1731.8%-100.0%<-9999.0%-100.0%-1660.9%
alltimeall time-100.0%-1731.8%-100.0%<-9999.0%-100.0%-2900.0%

Vascular Biogenics Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2023
-
$1000.00(>+9900.0%)
$23.00 K(+4.5%)
Dec 2022
$22.00 K(-100.0%)
$0.00(-100.0%)
$22.00 K(-99.8%)
Sep 2022
-
$22.00 K(>+9900.0%)
$9.83 M(-9.4%)
Jun 2022
-
$0.00(-100.0%)
$10.85 M(-77.9%)
Dec 2021
$49.11 M(+187.7%)
$9.81 M(+845.1%)
$49.11 M(+23.8%)
Sep 2021
-
$1.04 M(-96.0%)
$39.68 M(+3.3%)
Jun 2021
-
$26.18 M(+116.8%)
$38.41 M(+33.4%)
Mar 2021
-
$12.08 M(+3053.5%)
$28.78 M(+68.6%)
Dec 2020
$17.07 M(-4854.0%)
$383.00 K(-260.9%)
$17.07 M(+1.1%)
Sep 2020
-
-$238.00 K(-101.4%)
$16.88 M(-0.2%)
Jun 2020
-
$16.56 M(+4474.6%)
$16.92 M(+9299.4%)
Mar 2020
-
$362.00 K(+83.8%)
$180.00 K(-150.1%)
Dec 2019
-$359.00 K(-102.6%)
$197.00 K(-198.5%)
-$359.00 K(-44.3%)
Sep 2019
-
-$200.00 K(+11.7%)
-$644.00 K(+56.7%)
Jun 2019
-
-$179.00 K(+1.1%)
-$411.00 K(-103.0%)
Mar 2019
-
-$177.00 K(+101.1%)
$13.49 M(-1.3%)
Dec 2018
$13.67 M
-$88.00 K(-366.7%)
$13.67 M(-57.6%)
Sep 2018
-
$33.00 K(-99.8%)
$32.27 M(-1.8%)
Jun 2018
-
$13.72 M(>+9900.0%)
$32.88 M(+68.7%)
DateAnnualQuarterlyTTM
Mar 2018
-
$1000.00(-100.0%)
$19.49 M(-0.1%)
Dec 2017
$19.51 M(-11.2%)
$18.52 M(+2820.3%)
$19.51 M(+1790.5%)
Sep 2017
-
$634.00 K(+84.8%)
$1.03 M(+137.8%)
Jun 2017
-
$343.00 K(+1805.6%)
$434.00 K(-98.0%)
Mar 2017
-
$18.00 K(-51.4%)
$22.03 M(+0.2%)
Dec 2016
$21.98 M(+59.9%)
$37.00 K(+2.8%)
$21.98 M(-38.3%)
Sep 2016
-
$36.00 K(-99.8%)
$35.65 M(+0.1%)
Jun 2016
-
$21.94 M(<-9900.0%)
$35.62 M(+159.8%)
Mar 2016
-
-$32.00 K(-100.2%)
$13.71 M(-0.2%)
Dec 2015
$13.75 M(-65.7%)
$13.71 M(>+9900.0%)
$13.75 M(-60.6%)
Sep 2015
-
$10.00 K(-65.5%)
$34.92 M(+0.0%)
Jun 2015
-
$29.00 K(>+9900.0%)
$34.91 M(-12.9%)
Mar 2015
-
$0.00(-100.0%)
$40.08 M(-0.0%)
Dec 2014
$40.08 M(+300.8%)
$34.88 M(>+9900.0%)
$40.08 M(+670.1%)
Sep 2014
-
$0.00(-100.0%)
$5.21 M(0.0%)
Jun 2014
-
$5.20 M(>+9900.0%)
$5.21 M(>+9900.0%)
Mar 2014
-
$5000.00
$5000.00
Dec 2013
$10.00 M(>+9900.0%)
-
-
Dec 2012
$0.00
-
-

FAQ

  • What is Vascular Biogenics annual cash flow from financing activities?
  • What is the all time high annual CFF for Vascular Biogenics?
  • What is Vascular Biogenics annual CFF year-on-year change?
  • What is Vascular Biogenics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Vascular Biogenics?
  • What is Vascular Biogenics quarterly CFF year-on-year change?
  • What is Vascular Biogenics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Vascular Biogenics?
  • What is Vascular Biogenics TTM CFF year-on-year change?

What is Vascular Biogenics annual cash flow from financing activities?

The current annual CFF of VBLT is $22.00 K

What is the all time high annual CFF for Vascular Biogenics?

Vascular Biogenics all-time high annual cash flow from financing activities is $49.11 M

What is Vascular Biogenics annual CFF year-on-year change?

Over the past year, VBLT annual cash flow from financing activities has changed by -$49.09 M (-99.96%)

What is Vascular Biogenics quarterly cash flow from financing activities?

The current quarterly CFF of VBLT is $1000.00

What is the all time high quarterly CFF for Vascular Biogenics?

Vascular Biogenics all-time high quarterly cash flow from financing activities is $34.88 M

What is Vascular Biogenics quarterly CFF year-on-year change?

Over the past year, VBLT quarterly cash flow from financing activities has changed by +$1000.00 (+100.00%)

What is Vascular Biogenics TTM cash flow from financing activities?

The current TTM CFF of VBLT is $23.00 K

What is the all time high TTM CFF for Vascular Biogenics?

Vascular Biogenics all-time high TTM cash flow from financing activities is $49.11 M

What is Vascular Biogenics TTM CFF year-on-year change?

Over the past year, VBLT TTM cash flow from financing activities has changed by -$10.82 M (-99.79%)